Active Ingredient: DEXLANSOPRAZOLE
Proprietary Name: DEXILANT
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022287
Product Number: 002
Approval Date: Jan 30, 2009
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
